113 related articles for article (PubMed ID: 3272816)
1. HLA, C4, Bf, Gm and autoantibodies in rheumatoid arthritis.
Warlow RS; Uko G; Feeney DJ; Kay PH
Exp Clin Immunogenet; 1988; 5(2-3):133-42. PubMed ID: 3272816
[TBL] [Abstract][Full Text] [Related]
2. Extractable nuclear antigen (ENA) autoantibodies in SLE: an immunogenetic relationship with HLA, C4 and Bf alleles.
Warlow RS; Uko G; McCluskey J; Kay PH; Christiansen FT; Dawkins RL
Clin Exp Immunol; 1986 Feb; 63(2):419-27. PubMed ID: 3486067
[TBL] [Abstract][Full Text] [Related]
3. Antiacetylcholine receptor and antinuclear antibodies in myasthenia gravis. Correlation with HLA, sex and Gm.
Warlow RS; Garlepp M; Feeney D; Kay P; Swanson N; Dawkins RL
Exp Clin Immunogenet; 1985; 2(3):158-63. PubMed ID: 3917146
[TBL] [Abstract][Full Text] [Related]
4. HLA-A, B and DR antigens and properdin factor B allotypes in Caplan's syndrome.
Darke C; Wagner MM; Nuki G; Dyer PA
Br J Dis Chest; 1983 Jul; 77(3):235-42. PubMed ID: 6577907
[TBL] [Abstract][Full Text] [Related]
5. Immunogenetics of early-onset insulin-dependent diabetes mellitus among the Japanese: HLA, Gm, BF, GLO, and organ-specific autoantibodies--the J.D.S. study.
Mimura G; Kida K; Matsuura N; Toyota T; Kitagawa T; Kobayashi T; Hibi I; Ikeda Y; Tuchida I; Kuzuya H
Diabetes Res Clin Pract; 1990 Mar; 8(3):253-62. PubMed ID: 2340795
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of Gm(1,2;21) phenotype in HLA-DR4 positive seropositive rheumatoid arthritis.
Zarnowski H; Mierau R; Werdier D; Antons M; Genth E; Hartl PW
J Rheumatol; 1986 Oct; 13(5):858-63. PubMed ID: 3493344
[TBL] [Abstract][Full Text] [Related]
7. Genetic markers in rheumatoid arthritis.
Rantapää Dahlqvist S
Scand J Rheumatol Suppl; 1986; 58():1-29. PubMed ID: 3462903
[TBL] [Abstract][Full Text] [Related]
8. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
9. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
10. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin allotypes in rheumatoid arthritis.
Sanders PA; Grennan DM
Exp Clin Immunogenet; 1989; 6(1):99-108. PubMed ID: 2698223
[TBL] [Abstract][Full Text] [Related]
12. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
[TBL] [Abstract][Full Text] [Related]
13. Association of complement factor B allotypes and serum biomarkers in rheumatoid arthritis patients and their relatives.
Nass FR; Skare TL; Goeldner I; Nisihara R; Messias-Reason IJ; Utiyama SR
Int J Immunogenet; 2015 Dec; 42(6):439-44. PubMed ID: 26385602
[TBL] [Abstract][Full Text] [Related]
14. Interactive effect of HLA and Gm and genetic heterogeneity tested in 79 rheumatoid arthritis families.
Dizier MH; Silman AJ; Ollier W; Grennan DM; Clerget-Darpoux F
Dis Markers; 1991; 9(1):27-34. PubMed ID: 1742943
[TBL] [Abstract][Full Text] [Related]
15. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
16. Are major histocompatibility system class III products independent markers for susceptibility to rheumatoid arthritis?
Dyer PA; Thomson W; Sanders PA; Grennan DM
Dis Markers; 1986 Jun; 4(1-2):151-5. PubMed ID: 3330696
[TBL] [Abstract][Full Text] [Related]
17. Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome.
Saudan-Kister A; Gabay C; Tiercy JM; Mermillod B; Guerne PA; Vischer TL
Rev Rhum Engl Ed; 1996 May; 63(5):313-20. PubMed ID: 8789876
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR4 antigen and IgM rheumatoid factors.
Queirós MV; Sancho MR; Caetano JM
J Rheumatol; 1982; 9(3):370-3. PubMed ID: 6981703
[TBL] [Abstract][Full Text] [Related]
19. C3, BF and C4 polymorphisms in familial Mediterranean fever.
Davrinche C; Rivat C; Ollier-Hartmann MP; Hartmann L
Isr J Med Sci; 1985 Nov; 21(11):883-5. PubMed ID: 3852807
[TBL] [Abstract][Full Text] [Related]
20. Gm allotypes and HLA in rheumatoid arthritis patients with circulating antibodies to native type II collagen.
Sanders PA; Grennan DM; Klimiuk PS; Clague RB; deLange GG; Collins I; Dyer PA
Ann Rheum Dis; 1987 May; 46(5):391-4. PubMed ID: 3496057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
